Litifilimab (BIIB059) is a humanizedantibody targeting the plasma cell-like dendritic cell specific antigen (BDCA2) and C-type lectin structural domain family 4, member C (CLEC4C) for the study of cutaneous lupus erythematosus.
Purity:
97.40%
CAS Number:
[2407378-48-5]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted